Haemalogix Company

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.
Technology: Cancer
Industry: PharmTech
Headquarters: Sydney, New South Wales, Australia
Estimated Revenue: $1M to $10M

Visit Website
info@haemalogix.com
Register and Claim Ownership